Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


UPDATE: Arvnias Says ARV-471 Showed Evidence Of Anti-Tumor Activity, Co. Sees Initiation Of Combo Trial OF ARV-471 Plus Ibrance In December, Sees 3 Added Trials In Patients With Breast Cancer Beginning In 2021


Benzinga | Dec 14, 2020 07:38AM EST

UPDATE: Arvnias Says ARV-471 Showed Evidence Of Anti-Tumor Activity, Co. Sees Initiation Of Combo Trial OF ARV-471 Plus Ibrance In December, Sees 3 Added Trials In Patients With Breast Cancer Beginning In 2021






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC